Redwood City, CA · Founded 2018 · Privately Held (backing)
Operator of a biopharmaceutical company intended to offer investigational inhibitors for cancer treatment. Kartos Therapeutics is based in Redwood City, CA and was founded in 2018. It is valued at about $650 million as of Oct 2026, set by institutional fund marks. It has raised $265 million.
PMV mark · valuation
$650.0M
Oct 2026
Priced at
—
Total raised
$265.0M
Last round
—
Cap table — not yet on record
Kartos Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
